Abstract:The cellular and humoral responses that orchestrate fracture healing are still elusive. Here we report that bone morphogenic protein 2 (BMP2)-dependent fracture healing occurs through a tight control of chemokine C-X-C motif-ligand-12 (CXCL12) cellular, spatial, and temporal expression. We found that the fracture repair process elicited an early site-specific response of CXCL12(+)-BMP2(+) endosteal cells and osteocytes that was not present in unfractured bones and gradually decreased as healing progressed. Absence of a full complement of BMP2 in mesenchyme osteoprogenitors (BMP2(cKO/+)) prevented healing and led to a dysregulated temporal and cellular upregulation of CXCL12 expression associated with a deranged angiogenic response. Healing was rescued when BMP2(cKO/+) mice were systemically treated with AMD3100, an antagonist of CXCR4 and agonist for CXCR7 both receptors for CXCL12. We further found that mesenchymal stromal cells (MSCs), capable of delivering BMP2 at the endosteal site, restored fracture healing when transplanted into BMP2(cKO/+) mice by rectifying the CXCL12 expression pattern. Our in vitro studies showed that in isolated endosteal cells, BMP2, while inducing osteoblastic differentiation, stimulated expression of pericyte markers that was coupled with a decrease in CXCL12. Furthermore, in isolated BMP2(cKO/cKO) endosteal cells, high expression levels of CXCL12 inhibited osteoblastic differentiation that was restored by AMD3100 treatment or coculture with BMP2-expressing MSCs that led to an upregulation of pericyte markers while decreasing platelet endothelial cell adhesion molecule (PECAM). Taken together, our studies show that following fracture, a CXCL12(+)-BMP2(+) perivascular cell population is recruited along the endosteum, then a timely increase of BMP2 leads to downregulation of CXCL12 that is essential to determine the fate of the CXCL12(+)-BMP2(+) to osteogenesis while departing their supportive role to angiogenesis. Our findings have far-reaching implications for understanding mechanisms regulating the selective recruitment of distinct cells into the repairing niches and the development of novel pharmacological (by targeting BMP2/CXCL12) and cellular (MSCs, endosteal cells) interventions to promote fracture healing.

Hematopoietic Wnts Modulate Endochondral Ossification During Fracture Healing

Wnt Signaling:Essential Roles in Osteoblast Differentiation,bone Metabolism and Therapeutic Implications for Bone and Skeletal Disorders

Role of Wnt Signaling in Bone Remodeling and Repair

Modulation of Wnt signaling influences fracture repair

Wnt1 Boosts Fracture Healing by Enhancing Bone Formation in the Fracture Callus

An appropriate Wnt/β-catenin expression level during the remodeling phase is required for improved bone fracture healing in mice

Wnt pathway, an essential role in bone regeneration

Wnt Pathway in Bone Repair and Regeneration – What Do We Know So Far

Inhibition of Ss-Catenin Signaling in Chondrocytes Induces Delayed Fracture Healing in Mice

Activation of Wnt signaling in human fracture callus and nonunion tissues

Wnt-mediated Reciprocal Regulation Between Cartilage and Bone Development During Endochondral Ossification.

Tenascin-C promotes endochondral ossification and fracture healing through Hedgehog and Hippo signaling

Role of Wnt signaling in fracture healing

Contributed Mini Review : Role of Wnt Signaling in Fracture Healing

Bone Regeneration Is Regulated by Wnt Signaling

Roles of Wnt signalling in bone growth, remodelling, skeletal disorders and fracture repair

Modulation of Notch1 signaling regulates bone fracture healing

BMP2 Regulation of CXCL12 Cellular, Temporal, and Spatial Expression Is Essential During Fracture Repair

Fracture healing in a mouse model of Hajdu–Cheney-Syndrome with high turnover osteopenia results in decreased biomechanical stability

Wnt proteins promote bone regeneration.

Mesenchymal Cell‐Derived Juxtacrine Wnt1 Signaling Regulates Osteoblast Activity and Osteoclast Differentiation